Novo Nordisk Looks To Increase Its Global GLP-1 Lead

Strategy Includes Cementing Dominance In Obesity As Sales Growth Flattened In Q2

Beach_Binoculars
Novo Nordisk used its Q2 update to outline product transitions • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business